Clot formation in canine whole blood as measured by rotational thromboelastometry is influenced by sample handling and coagulation activator

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 7, 2010, Pages 692-702

  Smith, Stephanie A ^a   McMichael, Maureen ^b   Galligan, Alyssa ^b   Gilor, Shir ^b   Hoh, Crystal M ^b  

^a Department of Surgery   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

contact activation; hypercoagulability; thromboelastometry; tissue facto

Indexed keywords

ELLAGIC ACID; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; EX VIVO STUDY; FEMALE; HEMATOLOGICAL PROCEDURES; HEMOSTASIS; HUMAN; MALE; MATERIALS HANDLING; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; ROTATIONAL THROMBOELASTOMETRY; STORAGE;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; DOGS; HEMOSTASIS; HUMANS; SPECIMEN HANDLING; THROMBELASTOGRAPHY;

EID: 77958190176     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833e9c47     Document Type: Article

References (39)

1. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106:1366-1375.
2. Shima M, Matsumoto T, Ogiwara K. New assays for monitoring haemophilia treatment. Haemophilia 2008; 14 (Suppl 3):83-92. (Pubitemid 351722388)
3. Othman M, Powell S, Chirinian Y, Hegadorn C, Hopman W, Lillicrap D. Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise. Haemophilia 2009; 15:1126-1134.
4. Margaritis P, Roy E, Aljamali MN, Downey HD, Giger U, Zhou S, et al. Successful treatment of canine hemophilia by continuous expression of canine FVIIa. Blood 2009; 113:3682-3689.
5. Jiang H, Lillicrap D, Patarroyo-White S, Liu T, Qian X, Scallan CD, et al. Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs. Blood 2006; 108:107-115. (Pubitemid 43990618)
6. Summaria L, Sandesara J, Yang G, Vagher JP, Caprini JA. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chainstreptokinase complex in the dog model using pretitered doses. Thromb Haemost 1986; 56:71-79. (Pubitemid 16015920)
7. Vernese NA, Spillert CR, Franco CD, Lazaro EJ. Thromboelastographic evaluation of mini-dose heparin in minor surgical procedures. Am Surg 1986; 52:112-113.
8. Spillert CR, McGovern PJ, Vidaver RM, Lazaro EJ. Thromboelastographic evaluation of cut down-induced accelerated coagulation. Thromb Haemost 1981; 46:567.
9. Kristensen AT, Wiinberg B, Jessen LR, Andreasen E, Jensen AL. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22:140-147. (Pubitemid 351361463)
10. Wiinberg B, Jensen AL, Johansson PI, Rozanski E, Tranholm M, Kristensen AT. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008; 22:357-365. (Pubitemid 351570501)
11. Otto CM, Rieser TM, Brooks MB, Russell MW. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217:1500-1504.
12. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immunemediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care 2009; 19:484-488.
13. Wiinberg B, Jensen AL, Rozanski E, Johansson PI, Kjelgaard-Hansen M, Tranholm M, Kristensen AT. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 2009; 179:121-129.
14. Camenzind V, Bombeli T, Seifert B, Jamnicki M, Popovic D, Pasch T, Spahn DR. Citrate storage affects thrombelastograph analysis. Anesthesiology 2000; 92:1242-1249. (Pubitemid 30257182)
15. Mann KG, Whelihan MF, Butenas S, Orfeo T. Citrate anticoagulation and the dynamics of thrombin generation. J Thromb Haemost 2007; 5:2055-2061. (Pubitemid 47450024)
16. Mancuso A, Fung K, Cox D, Mela M, Patch D, Burroughs AK. Assessment of blood coagulation in severe liver disease using thromboelastography: use of citrate storage versus native blood. Blood Coagul Fibrinolysis 2003; 14:211-216. (Pubitemid 36332486)
17. Wiinberg B, Jensen AL, Rojkjaer R, Johansson P, Kjelgaard-Hansen M, Kristensen AT. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34:389-393. (Pubitemid 43036133)
18. Brainard BM, Meredith CP, Callan MB, Budsberg SC, Shofer FS, Driessen B, Otto CM. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 2007; 68:251-257. (Pubitemid 46487509)
19. Vilar P, Couto CG, Westendorf N, Iazbik C, Charske J, Marin L. Thromboelastographic tracings in retired racing greyhounds and in nongreyhound dogs. J Vet Intern Med 2008; 22:374-379. (Pubitemid 351570503)
20. Bauer N, Eralp O, Moritz A. Establishment of reference intervals for kaolinactivated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use. J Vet Diagn Invest 2009; 21:641-648.
21. Jessen LR, Wiinberg B, Jensen AL, Kjelgaard-Hansen M, Jensen KH, Pedersen LB, Kristensen AT. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dosedependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time. Vet Clin Pathol 2008; 37:363-372.
22. Wiinberg B, Jensen AL, Kjelgaard-Hansen M, Rojkjaer R, Johansson PI, Gade LP, et al. Study on biological variation of haemostatic parameters in clinically healthy dogs. Vet J 2007; 174:62-68. (Pubitemid 46865744)
23. Wagg CR, Boysen SR, Bedard C. Thrombelastography in dogs admitted to an intensive care unit. Vet Clin Pathol 2009; 38:453-461.
24. Rose L, Bedard C, Dunn M. Effect of prednisone administration on thromboelastography parameters in healthy beagles [abstract]. J Vet Intern Med 2008;22:738-739.
25. Jugdutt BI. The dog model of left ventricular remodeling after myocardial infarction. J Card Fail 2002; 8:S472-S475. (Pubitemid 36083099)
26. Prasad S, Lillicrap D, Labelle A, Knappe S, Keller T, Burnett E, et al. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood 2008; 111:672-679.
27. Zambruni A, Thalheimer U, Leandro G, Perry D, Burroughs AK. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004; 15:103-107. (Pubitemid 38534694)
28. Smith SA. The cell-based model of coagulation. J Vet Emerg Crit Care (San Antonio) 2009; 19:3-10.
29. Roche AM, James MF, Grocott MP, Mythen MG. Just scratching the surface: varied coagulation effects of polymer containers on TEG variables. Eur J Anaesthesiol 2006; 23:45-49.
30. Johansson PI, Bochsen L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion 2008; 48:2377-2383.
31. Sorensen B, Asvaldsdottir HS, Gudmundsdottir BR, Onundarson PT. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery. Thromb Res 2009; 124:695-700.
32. Larsen OH, Clausen N, Persson E, Ezban M, Ingerslev J, Sorensen B. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue. Br J Haematol 2009; 144:99-106.
33. van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, Makris M. Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A. Thromb Res 2009; 123:895-901.
34. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009; 67:266-275.
35. Park MS, Salinas J, Wade CE, Wang J, Martini W, Pusateri AE, et al. Combining early coagulation and inflammatory status improves prediction of mortality in burned and nonburned trauma patients. J Trauma 2008; 64:S188-S194.
36. Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography. Blood Coagul Fibrinolysis 2007; 18:547-553. (Pubitemid 47344302)
37. Nielsen VG. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007; 18:247-252.
38. Morrissey JH. Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol 2004; 79:103-108.
39. Gailani D, Renne T. The intrinsic pathway of coagulation: A target for treating thromboembolic disease? J Thromb Haemost 2007; 5:1106-1112. (Pubitemid 46902107)